Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected resultsBreast cancer research and treatment, 2017-02, Vol.161 (3), p.575-586 [Peer Reviewed Journal]The Author(s) 2016 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-4085-4 ;PMID: 28008555 ;CODEN: BCTRD6Full text available |
|
2 |
Material Type: Article
|
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patientsBreast cancer research and treatment, 2013-01, Vol.137 (2), p.465-470 [Peer Reviewed Journal]Springer Science+Business Media New York 2012 ;2014 INIST-CNRS ;COPYRIGHT 2013 Springer ;Springer Science+Business Media New York 2013 ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-012-2355-3 ;PMID: 23224235 ;CODEN: BCTRD6Full text available |
|
3 |
Material Type: Article
|
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohortBritish journal of cancer, 2019-12, Vol.121 (12), p.991-1000 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0619-y ;PMID: 31719684Full text available |
|
4 |
Material Type: Article
|
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trialThe lancet oncology, 2017-06, Vol.18 (6), p.743-754 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30313-3 ;PMID: 28526538Full text available |
|
5 |
Material Type: Article
|
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancerBreast cancer research and treatment, 2018-05, Vol.169 (1), p.105-113 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4661-x ;PMID: 29335925Full text available |
|
6 |
Material Type: Article
|
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trialThe lancet oncology, 2017-06, Vol.18 (6), p.732-742 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30312-1 ;PMID: 28526536Full text available |
|
7 |
Material Type: Article
|
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)The lancet oncology, 2012-04, Vol.13 (4), p.e148-e160 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2012 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(11)70383-7 ;PMID: 22469125 ;CODEN: LANCAOFull text available |
|
8 |
Material Type: Article
|
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant ChemotherapyAnnals of surgical oncology, 2018-09, Vol.25 (9), p.2596-2602 [Peer Reviewed Journal]Society of Surgical Oncology 2018 ;Annals of Surgical Oncology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-018-6637-9 ;PMID: 29978369Full text available |
|
9 |
Material Type: Article
|
Treatments for breast cancer in men: late effects and impact on quality of lifeBreast cancer research and treatment, 2023-10, Vol.201 (3), p.489-498 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-023-07027-6 ;PMID: 37418032Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Prognostic factors in male breast cancer: a population-based studyBreast cancer research and treatment, 2016-04, Vol.156 (3), p.539-548 [Peer Reviewed Journal]Springer Science+Business Media New York 2016 ;COPYRIGHT 2016 Springer ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-3768-1 ;PMID: 27039306 ;CODEN: BCTRD6Full text available |
|
11 |
Material Type: Article
|
The prognostic significance of tumour―stroma ratio in oestrogen receptor-positive breast cancerBritish journal of cancer, 2014-04, Vol.110 (7), p.1744-1747 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright Nature Publishing Group Apr 1, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.69 ;PMID: 24548861 ;CODEN: BJCAAIFull text available |
|
12 |
Material Type: Article
|
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristicsPloS one, 2022-02, Vol.17 (2), p.e0264637-e0264637 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Nelson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Nelson et al 2022 Nelson et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0264637 ;PMID: 35213669Full text available |
|
13 |
Material Type: Article
|
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysisBMC cancer, 2016-07, Vol.16 (1), p.375-375, Article 375 [Peer Reviewed Journal]COPYRIGHT 2016 BioMed Central Ltd. ;COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;The Author(s). 2016 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-016-2414-y ;PMID: 27377827Full text available |
|
14 |
Material Type: Article
|
Cytoplasmic DDX3 as prognosticator in male breast cancerVirchows Archiv : an international journal of pathology, 2021-10, Vol.479 (4), p.647-655 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0945-6317 ;EISSN: 1432-2307 ;DOI: 10.1007/s00428-021-03107-4 ;PMID: 33974127Full text available |
|
15 |
Material Type: Article
|
Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinationsJournal of cancer research and clinical oncology, 2022-02, Vol.148 (2), p.441-447 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-021-03623-5 ;PMID: 33991247Full text available |
|
16 |
Material Type: Article
|
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trialThe lancet oncology, 2020-10, Vol.21 (10), p.1331-1340 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30456-3 ;PMID: 33002437Full text available |
|
17 |
Material Type: Article
|
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysisBritish journal of cancer, 2019-02, Vol.120 (3), p.301-305 [Peer Reviewed Journal]This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-018-0369-2 ;PMID: 30655614Full text available |
|
18 |
Material Type: Article
|
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trialThe lancet oncology, 2020-10, Vol.21 (10), p.1341-1352 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30454-X ;PMID: 33002438Full text available |
|
19 |
Material Type: Article
|
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interfaceBritish journal of cancer, 2014-01, Vol.110 (2), p.535-545 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright Nature Publishing Group Jan 21, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.730 ;PMID: 24346285 ;CODEN: BJCAAIFull text available |
|
20 |
Material Type: Article
|
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialThe lancet oncology, 2015-03, Vol.16 (3), p.274-283 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 2015 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70482-6 ;PMID: 25656287 ;CODEN: LANCAOFull text available |